May 03, 2022 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to Veracyte's First Quarter 2022 Financial Results Conference Call. (Operator Instructions) As a reminder, today's conference call is being recorded.
I'd now like to turn the conference over to Shayla Gorman, Veracyte's Director of Investor Relations. You may begin.
Shayla Gorman;Veracyte - Inc.;Director - Investor Relations,
Good afternoon, everyone, and thanks for joining us today for a discussion of our first quarter 2022 financial results. With me today are Marc Stapley, Veracyte's Chief Executive Officer; Rebecca Chambers, our Chief Financial Officer; Dr. Tina Nova, President of our U.S. CLIA business; and Dr. Giulia Kennedy, Global Chief Scientific Officer and Chief Medical Officer.
Veracyte issued a press release earlier this afternoon detailing our first quarter 2022 financial results. This news release, along with the business and financial presentation is available in the Investor Relations section of our website at veracyte.com. Before we
Q1 2022 Veracyte Inc Earnings Call Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers